| Identification | Back Directory | [Name]
3,5,8-Trioxa-4-phosphadecanoic acid, 4-[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]-9,9-dimethyl-7-oxo-, 1,1-dimethylethyl ester, 4-oxide | [CAS]
2140902-80-1 | [Synonyms]
Thyroid hormone receptor beta agonist-1
3,5,8-Trioxa-4-phosphadecanoic acid, 4-[[4-[[4-hydroxy-3-(phenylmethyl)phenyl]methyl]-3,5-dimethylphenoxy]methyl]-9,9-dimethyl-7-oxo-, 1,1-dimethylethyl ester, 4-oxide | [Molecular Formula]
C35H45O9P | [MOL File]
2140902-80-1.mol | [Molecular Weight]
640.7 |
| Chemical Properties | Back Directory | [Boiling point ]
730.1±60.0 °C(Predicted) | [density ]
1.175±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [pka]
10.39±0.30(Predicted) |
| Hazard Information | Back Directory | [Uses]
Thyroid hormone receptor beta agonist-1 (compound 3) is a thyroid beta-agonist[1]. | [References]
[1] Hongjian Jiang, et al. Use of thyroid beta-agonists. Patent WO2017185087A1. |
|
| Company Name: |
Biorbyt Ltd.
|
| Tel: |
+44 (0)1223 859 353 |
| Website: |
www.biorbyt.com |
|